Cargando…
Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion
The molecular chaperone Hsp90 is overexpressed in prostate cancer (PCa) and is responsible for the folding, stabilization and maturation of multiple oncoproteins, which are implicated in PCa progression. Compared to first-in-class Hsp90 inhibitors such as 17-allylamino-demethoxygeldanamycin (17-AAG)...
Autores principales: | Armstrong, Heather K., Gillis, Joanna L., Johnson, Ian R. D., Nassar, Zeyad D., Moldovan, Max, Levrier, Claire, Sadowski, Martin C., Chin, Mei Yieng, Tomlinson Guns, Emma S., Tarulli, Gerard, Lynn, David J., Brooks, Douglas A., Selth, Luke A., Centenera, Margaret M., Butler, Lisa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794796/ https://www.ncbi.nlm.nih.gov/pubmed/29391407 http://dx.doi.org/10.1038/s41598-018-19871-4 |
Ejemplares similares
-
Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors
por: Gillis, Joanna L., et al.
Publicado: (2013) -
Hsp90 Binds Directly to Fibronectin (FN) and Inhibition Reduces the Extracellular Fibronectin Matrix in Breast Cancer Cells
por: Hunter, Morgan C., et al.
Publicado: (2014) -
HSP90 Interacts with the Fibronectin N-terminal Domains and Increases Matrix Formation
por: Chakraborty, Abir, et al.
Publicado: (2020) -
Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer
por: Hinneh, Josephine A., et al.
Publicado: (2023) -
Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes
por: Kharmate, Geetanjali, et al.
Publicado: (2016)